Autel Intelligent Technology Corp., Ltd. (SHA:688208)

Regulus Therapeutics Revenue

Autel Intelligent Technology Corp. had revenue of 1.09B CNY in the quarter ending March 31, 2025, with 26.71% growth. This brings the company's revenue in the last twelve months to 4.16B, up 22.14% year-over-year. In the year 2024, Autel Intelligent Technology Corp. had annual revenue of 3.93B with 20.95% growth.

• Revenue (ttm): 4.16B
• Revenue Growth: +22.14%
• P/S Ratio: 5.78
• Revenue / Employee: 1.52M
• Employees: 2,744
• Market Cap: 24.08B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.93B	681.10M	20.95%
Dec 31, 2023	3.25B	985.60M	43.50%
Dec 31, 2022	2.27B	11.84M	0.53%
Dec 31, 2021	2.25B	675.94M	42.84%
Dec 31, 2020	1.58B	381.98M	31.94%